Approve Suite — A continuously refreshed, machine-readable regulatory-event stream built over eight public U.S. sources (FDA warning letters, FDA inspection classifications, openFDA recalls, Federal Register, eCFR Title 21, ClinicalTrials.gov, Drugs@FDA approvals and complete response letters, SEC EDGAR 8-K disclosures), where each raw record is re-published as a normalised event carrying a written summary, a 'why it matters' explanation, the CFR sections cited, a GxP-area tag, a severity tier, and a resolved company/indication/product-type identity — plus company profiles that fuse the FDA r…
Approve Suite — A continuously refreshed, machine-readable regulatory-event stream built over eight public U.S. sources (FDA warning letters, FDA inspection classifications, openFDA recalls, Federal Register, eCFR Title 21, ClinicalTrials.gov, Drugs@FDA approvals and complete response letters, SEC EDGAR 8-K disclosures), where each raw record is re-published as a normalised event carrying a written summary, a 'why it matters' explanation, the CFR sections cited, a GxP-area tag, a severity tier, and a resolved company/indication/product-type identity — plus company profiles that fuse the FDA r…
Approve Suite offers (Alternative, Sentiment, Reference) — Eight source feeds ingested continuously — inspections and approvals refreshed daily, the rest every two to six hours — annotated one record at a time with a summary, a relevance explanation and CFR/GxP tags. FDA publishes warning letters in the low hundreds per year, inspection classifications in the thousands, recalls in the tens of thousands, Title 21 Federal Register items and section-level eCFR amendments in the thousands, trial registration and status changes in the tens of thousands, approvals and complete response letters in the hundreds, and matching 8-K disclosures in the low thousands — so the annotated archive is plausibly in the high hundreds of thousands of enriched event records at a few hundred tokens of generated annotation each..
Training and evaluating grounded retrieval-augmented assistants on regulatory corpora (every answer ships with the event IDs it used, which is a ready-made citation-supervision pair); training triage classifiers that sort regulatory documents into urgency tiers; event studies measuring the share-price impact of complete response letters, clinical holds, Form 483s and OAI inspections on listed biotech issuers; entity-resolution models that link FDA, ClinicalTrials.gov and SEC identifiers to one company; and competitor-pipeline or counterparty-monitoring signals for CDMO and CRO customers.
Coverage spans US; Biotechnology, Pharmaceuticals, Research & Consulting Services; alternative, sentiment, reference; equities.
Not yet on file: Summary & mission · Use cases & buyers · FAQ